Thrombocytopenia: Case definition and guidelines for collection, analysis, and presentation of immunization safety data-Reference-Cited by-同舟云学术

Thrombocytopenia: Case definition and guidelines for collection, analysis, and presentation of immunization safety data

Published:2007-08 Issue:31 Volume:25 Page:5717-5724
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Wise Robert P.,Bonhoeffer Jan,Beeler Judy,Donato Hugo,Downie Peter,Matthews Dana,Pool Vitali,Riise-Bergsaker Marianne,Tapiainen Terhi,Varricchio Frederick

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference53 articles.

1. Immune thrombocytopenic purpura, neonatal alloimmune thrombocytopenia and posttransfusion purpura;Bussel,2000

2. Platelet an blood vessel disorders;Montgomery,2004

3. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group;Kuhne;J Pediatr,2003

4. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy;British Committee for Standards in Haematology General Haematology Task Force;Br J Haematol,2003

5. Immune thrombocytopenic purpura after recombinant hepatitis B vaccine: retrospective study of seven cases;Neau;Scand J Infect Dis,1998

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data;Vaccine;2024-03

2. Safety of Immunization for Children with Immune Thrombocytopenia;Vaccines;2024-01-09

3. Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two self-controlled studies in the U.S.;Vaccine;2023-07

4. Profiling COVID-19 Vaccine Adverse Events by Statistical and Ontological Analysis of VAERS Case Reports;Frontiers in Pharmacology;2022-06-24

5. Enhanced surveillance for adverse events following immunization during the 2019 typhoid conjugate vaccine campaign in Harare, Zimbabwe;Vaccine;2022-06